ReviewInternational journal of molecular sciences2021

Targeting the Angiotensin II Type 1 Receptor in Cerebrovascular Diseases: Biased Signaling Raises New Hopes.

Céline Delaitre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.